0001209191-16-117514.txt : 20160504
0001209191-16-117514.hdr.sgml : 20160504
20160504181540
ACCESSION NUMBER: 0001209191-16-117514
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140414
FILED AS OF DATE: 20160504
DATE AS OF CHANGE: 20160504
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BG Medicine, Inc.
CENTRAL INDEX KEY: 0001407038
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043506204
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 880 WINTER STREET
STREET 2: SUITE 210
CITY: WALTHAM
STATE: MA
ZIP: 02451
BUSINESS PHONE: 781-890-1199
MAIL ADDRESS:
STREET 1: 880 WINTER STREET
STREET 2: SUITE 210
CITY: WALTHAM
STATE: MA
ZIP: 02451
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Adourian Aram S.
CENTRAL INDEX KEY: 0001506699
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33827
FILM NUMBER: 161620950
MAIL ADDRESS:
STREET 1: C/O BG MEDICINE, INC.
STREET 2: 610 LINCOLN STREET NORTH
CITY: WALTHAM
STATE: MA
ZIP: 02451
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-04-14
0
0001407038
BG Medicine, Inc.
BGMD
0001506699
Adourian Aram S.
C/O BG MEDICINE, INC.
303 WYMAN STREET, SUITE 300
WALTHAM
MA
02451
0
1
0
0
SVP & Chief Scientific Officer
Common Stock
2014-04-14
4
M
0
12000
0.90
A
40036
D
Stock Option (right to buy)
0.90
2014-04-14
4
M
0
12000
0.00
D
2014-04-15
Common Stock
12000
16036
D
The reporting person paid cash for the exercise price. The share and exercise price figures in this report do not reflect the 1-for-4 reverse stock split of the issuer's common stock effected on July 8, 2015.
All of the shares underlying this option were vested and the option expired on April 15, 2014.
/s/ John P. Condon, Attorney-in-fact
2016-05-04